{'fraction_non_alphanumeric': 0.01859504132231405, 'fraction_numerical': 0.01652892561983471, 'mean_word_length': 5.830985915492958, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck

The current study was conducted to identify prognostic factors and report the characteristics of long‐term survivors in patients with recurrent or metastatic carcinoma of the head and neck who were treated with cisplatin‐based combination chemotherapy in two randomized, Phase III trials conducted by the Eastern Oncology Cooperative Group (ECOG) (E1393 and E1395).